Dr. Jimenez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1998 - 2001
Pontifical Xavierian UniversityClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2007 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers Start of enrollment: 2019 Jun 13
Publications & Presentations
PubMed
- 193 citationsVitamin D deficiency and seasonal variation in an adult south Florida populationSilvina Levis, Angela Gomez, Camilo Jimenez, Luis Veras, Fangchao Ma
The Journal of Clinical Endocrinology and Metabolism. 2005-03-01 - 17 citationsEndocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?Camilo Jimenez, Gustavo Armaiz-Pena, Patricia L M Dahia, Yang Lu, Rodrigo A Toledo
Cancers. 2022-01-18 - 142 citationsTreatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.Montserrat Ayala-Ramirez, Cecile N Chougnet, Mouhammed Amir Habra, J. Lynn Palmer, Sophie Leboulleux
The Journal of Clinical Endocrinology and Metabolism. 2012-09-10
Lectures
- Pheochromocytoma and Paraganglioma: Perioperative, Management, Surveillance, and New Imaging Modalities (Repeat)ENDO 2019 - New Orleans, LA - 3/23/2019
- Clinical Management of Adrenocortical CarcinomaENDO 2019 - New Orleans, LA - 3/24/2019
- Adrenal Tumors and HyperplasiaENDO 2019 - New Orleans, LA - 3/24/2019
- Join now to see all
Press Mentions
- Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021March 22nd, 2021
MD Anderson Research Highlights for April 24, 2024April 25th, 2024- Cabozantinib Promising for Metastatic Pheochromocytomas, ParagangliomasApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
